Ann: Alterity to Deliver Multiple Presentations at MDS Congress, page-24

Hi tuts,

I read the attached article, its a replication to the article posted by pivalde afew days back, just posted by a different company/organisation/site.

Highlighting the headline, afew sites have posted the same piece of the article (4 to be precise just in a google search)

Looking down further in the search, ATH434, seems to be gaining traction with its potential use in FA.

Posted 7th May 2024, Dr Stamler also making comment within this report, regarding ATH434s use in FA -

https://friedreichsataxianews.com/news/ath434-may-target-toxic-iron-clusters-drive-fa/

Rare disease Advisor also posted a similar article on the 7th May, also making a statement that ATH434 is intended for the treatment of FA....agghhh what, pretty sure they are aiming for MSA, than parkinsons, than the world......mwahahahaha

https://www.rarediseaseadvisor.com/news/data-durg-candidat-fa/